ESMO Preceptorship on Immuno-Oncology 2019: Zurich
Application deadline: 1 March 2019
Our journals offer ESMO members and the oncology community a globally visible platform to publish scientific studies, and a highly credible source of educational updates.
There are many good reasons to become an ESMO member. Find out why you should join Europe's leading medical oncology society
An annual Congress providing a comprehensive overview of all the practice-changing new data. Register now!
The ESMO-MCBS scale is a validated and reproducible tool to assess the magnitude of clinical benefit for cancer medicines.
Veronika Ballová explains how this attractive and interactive book gives a complete overview of what is essential in the rapidly moving field of leukaemia and myeloma. Veronika Ballová is co-editor of the ESMO Leukaemia and Myeloma: Essentials for Clinicians and a member of the ESMO Publishing Working Group.
19 Feb 2019
ESMO would like to thank Dr Gustavo A. López for his help in the Spanish translation
18 Feb 2019
Summary report of the Heads of Medicines Agencies – EMA Joint Big Data task force
15 Feb 2019
LifeTime and RESTORE among shortlisted projects
14 Feb 2019
Axumin is a radiopharmaceutical agentfor functional imaging of prostate cancer recurrence
13 Feb 2019
Increase in accrual capacity and the quality standards
12 Feb 2019
Both contain the active substance pegfilgrastim and were developed as a biosimilar medicine
Valencia, Spain
22 Feb
- 22 Feb
2019
Paris, France
25 Feb
- 27 Feb
2019
Manchester, United Kingdom
06 Mar
- 08 Mar
2019
Barcelona, Spain
14 Mar
- 16 Mar
2019
Sao Paulo, Brazil
22 Mar
- 24 Mar
2019
Geneva, Switzerland
10 Apr
- 13 Apr
2019
